Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

1998 • 9,382 citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

1997 • 2,670 citations

Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

2002 • 2,438 citations

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

2003 • 1,614 citations

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

1998 • 637 citations

Advances in vaccine adjuvants

1999 • 497 citations

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1998 • 409 citations

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

2002 • 374 citations

Recent developments in adjuvants for vaccines against infectious diseases

2001 • 339 citations

Adjuvant effects of IL-1β, IL-2, IL-8, IL-15, IFN-α, IFN-γ TGF-β4 and lymphotactin on DNA vaccination against Eimeria acervulina

2001 • 219 citations

Genetic adjuvants for DNA vaccines

2001 • 182 citations

Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice

2002 • 123 citations

Genetic immunization: a new era in vaccines and immune therapeutics

1997 • 116 citations

DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans

1998 • 106 citations

Cytokines and costimulatory molecules as genetic adjuvants

1997 • 102 citations

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

2002 • 99 citations

Combined Administration of Plasmids Encoding IL-4 and IL-10 Prevents the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

2001 • 95 citations

The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-γ–producing cells

2003 • 88 citations

Regulation of Drosophila α- and β-tubulin genes during development

1984 • 87 citations

Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses

1999 • 83 citations

DNA vaccines for viral diseases

1999 • 79 citations

Imiquimod

2003 • 68 citations

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

2001 • 65 citations

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

2002 • 64 citations

DNA vaccines--challenges in delivery.

2000 • 54 citations

Immunomodulation as a treatment strategy for genital herpes: review of the evidence

2002 • 50 citations

Revealing the Potential of DNA-Based Vaccination: Lessons Learned from the Hepatitis B Virus Surface Antigen

2001 • 45 citations

Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant

2003 • 43 citations

Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine

2000 • 41 citations

Novel dermatologic uses of the immune response modifier imiquimod 5% cream.

2002 • 38 citations

Safety and immunogenicity of intramuscular and intravaginal delivery of HIV‐1 DNA constructs to infant chimpanzees

1997 • 38 citations

Co-immunization of rhesus macaques with plasmid vectors expressing IFN-γ, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus

2002 • 37 citations

Correlates of protection in HIV infection and the progression of HIV infection to AIDS

1996 • 35 citations

Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants

2001 • 32 citations

HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection

2003 • 31 citations

The immunology of HIV-infected long-term non-progressors—a current view

2001 • 30 citations

The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.

1998 • 24 citations

Interleukin-1 and Interleukin-1 Fragments as Vaccine Adjuvants

1999 • 24 citations

Immunoadjuvants and analogs of immunomodulatory bacterial structures

1989 • 23 citations

Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees

1998 • 23 citations

NEXT GENERATION DNA VACCINES FOR HIV-1

2002 • 21 citations

The Rational Design of Vaccine Adjuvants for Mucosal and Neonatal Immunization

2001 • 21 citations

Gene vaccines

1996 • 18 citations

Viral Reservoirs an Impediment to HAART: New Strategies to Eliminate HIV-1

2003 • 18 citations

Rate, Causes, and Clinical Implications of Presenting with Low CD4⁺ Cell Counts in the Era of Highly Active Antiretroviral Therapy

2003 • 18 citations

Novel adjuvants and delivery systems for HIV vaccines

2002 • 15 citations

Engineering of DNA vaccines using molecular adjuvant plasmids.

2000 • 15 citations

Delivery systems and adjuvants for vaccination against HIV

2000 • 8 citations

Ongoing trials of immune-based therapies for HIV infection in adults

2001 • 6 citations

[Adjuvants: update on concepts].

1990 • 1 citations